|
[Related PubMed/MEDLINE] Total Number of Papers: 2355
|
|
|
[Display Entries]
|
|
|
[Entries Per Page]
|
per page
|
|
Page Control
|
|
Page: of
|
|
|
|
Abbreviation |
: cART |
Long Form |
: combination antiretroviral therapy |
|
No. |
Year |
Title |
Co-occurring Abbreviation |
1 |
2021 |
Important role of microglia in HIV-1 associated neurocognitive disorders and the molecular pathways implicated in its pathogenesis. |
CNS, HAND, HIV-1, ROS |
2 |
2020 |
A pivotal role for Interferon-alpha receptor-1 in neuronal injury induced by HIV-1. |
CNS, HAND, IFNAR, IFNAR1KO, tg |
3 |
2020 |
Absence of peripapillary retinal nerve-fiber-layer thinning in combined antiretroviral therapy-treated, well-sustained aviremic persons living with HIV. |
CSVD, GCL, HUCs, MRI, PLHIVs, pRNFL, SD-OCT |
4 |
2020 |
Adeno-Associated Viral Vector Mediated Expression of Broadly- Neutralizing Antibodies Against HIV-Hitting a Fast-Moving Target. |
AAV, bNAbs |
5 |
2020 |
Adherence to Antiretroviral Regimens in Australia: A Nationwide Cohort Study. |
GBTM |
6 |
2020 |
Advances in Developing CAR T-Cell Therapy for HIV Cure. |
AIDS, CAR-T |
7 |
2020 |
An Integrated Spatial Dynamics-Pharmacokinetic Model Explaining Poor Penetration of Anti-retroviral Drugs in Lymph Nodes. |
LNs, PK/PD |
8 |
2020 |
An observational study of initial HIV RNA decay following initiation of combination antiretroviral treatment during pregnancy. |
pVL |
9 |
2020 |
Anemia and Micronutrient Status during Pregnancy, and Their Associations with Obstetric and Infant Outcomes among HIV-Infected Ugandan Women Receiving Antiretroviral Therapy. |
ART, Hb, PI, PIs, SGA, WLHIV |
10 |
2020 |
Anti-HIV Activity of Standard Combined Antiretroviral Therapy in Primary Cells Is Intensified by CCR5-Targeting Drugs. |
--- |
11 |
2020 |
Anti-HIV-1 Antibodies: An Update. |
bNAbs |
12 |
2020 |
Assessing the impact of food insecurity on HIV medication adherence in the context of an integrated care programme for people living with HIV in Vancouver, Canada. |
aOR, PLHIV |
13 |
2020 |
Assessment of lamivudine, zidovudine, lopinavir, and ritonavir plasma levels in HIV-positive pregnant women: Drug monitoring application to improve patient safety. |
HIV, LMV, LPV, MRM, PIs, RTV, TDM, ZDV |
14 |
2020 |
Association of Lower Adiponectin Plasma Levels, Increased Age and Smoking with Subclinical Atherosclerosis in Patients with HIV-1 Infection. |
CIMT, CVD, HIV-1, IL, USGD |
15 |
2020 |
B-cell clonogenic activity of HIV-1 p17 variants is driven by PAR1-mediated EGF transactivation. |
vp17s |
16 |
2020 |
Blood mitochondrial DNA levels remain elevated from birth to early life in children HIV-exposed uninfected exposed to combination antiretroviral therapy in utero. |
CHEU, CHUU, mtDNA |
17 |
2020 |
Bone mineral density changes among people living with HIV who have started with TDF-containing regimen: A five-year prospective study. |
aOR, BMD, DEXA, FN, LS, PLHIV, TDF, TH |
18 |
2020 |
Breastfeeding by Women Living With Human Immunodeficiency Virus in a Resource-Rich Setting: A Case Series of Maternal and Infant Management and Outcomes. |
HIV |
19 |
2020 |
Broadly neutralizing antibodies for HIV-1: efficacies, challenges and opportunities. |
bNAbs, HIV-1 |
20 |
2020 |
CD4+:CD8+ T Cell Ratio Normalization and the Development of AIDS Events in People with HIV Starting Antiretroviral Therapy. |
--- |
21 |
2020 |
CD4/CD8 Ratio Recovery of Children and Adolescents Living With HIV With Virological Suppression: A Prospective Cohort Study. |
HIV, PYFU |
22 |
2020 |
Cervical, anal and oral human papillomavirus (HPV) infection in young women: A case control study between women with perinatally HIV infection and women with non-perinatally HIV infection. |
HPV, HR-HPV |
23 |
2020 |
Challenges to achieving and maintaining viral suppression among children living with HIV. |
aHR, aOR, CI |
24 |
2020 |
Changes in functional connectivity in people with HIV switching antiretroviral therapy. |
DAN, INSTI, NNRTI, PWH, SSRT |
25 |
2020 |
Characterizing the Latent HIV-1 Reservoir in Patients with Viremia Suppressed on cART: Progress, Challenges, and Opportunities. |
AIDS |
26 |
2020 |
Clinical Correlates of Human Immunodeficiency Virus-1 (HIV-1) DNA and Inducible HIV-1 RNA Reservoirs in Peripheral Blood in Children With Perinatally Acquired HIV-1 Infection With Sustained Virologic Suppression for at Least 5 Years. |
HIV-1, SVS |
27 |
2020 |
Clinical Features and CD4+ T Cells Count in AIDS Patients with CMV Retinitis: Correlation with Mortality. |
AIDS, CMV, CMVR |
28 |
2020 |
Clinical manifestations and risk factors for oral immune reconstitution inflammatory syndrome in Mexico. |
IRIS, IRIS-OLs, PLWH |
29 |
2020 |
Clinico-Immunological Status and Neurocognitive Function of Perinatally Acquired HIV-Positive Children on cART: A Cross-Sectional Correlational Study in South Africa. |
PHIV |
30 |
2020 |
Comparative Immunovirological and Clinical Responses to Antiretroviral Therapy Between HIV-1 Group O and HIV-1 Group M Infected Patients. |
--- |
31 |
2020 |
Composition and Orientation of the Core Region of Novel HIV-1 Entry Inhibitors Influences Metabolic Stability. |
--- |
32 |
2020 |
Considerations on nosology for HIV-associated neurocognitive disorders: it is time to update? |
ANI, HAND |
33 |
2020 |
Correlates of health-related quality of life among adults receiving combination antiretroviral therapy in coastal Kenya. |
FAHI, HRQoL, PLWHA |
34 |
2020 |
COVID-19 and AIDS: Outcomes from the coexistence of two global pandemics and the importance of chronic antiretroviral therapy. |
AIDS, COVID-19, HIV, SARS-CoV-2 |
35 |
2020 |
CRF01_AE and CRF01_AE cluster 4 are associated with poor immune recovery in Chinese patients under cART. |
IR |
36 |
2020 |
Dasatinib protects humanized mice from acute HIV-1 infection. |
CML, GALT, TKIs |
37 |
2020 |
Decreased All-Cause and Liver-Related Mortality Risk in HIV/Hepatitis B Virus Coinfection Coinciding With the Introduction of Tenofovir-Containing Combination Antiretroviral Therapy. |
aHR, HBV |
38 |
2020 |
Decreased time to viral suppression after implementation of targeted testing and immediate initiation of treatment of acute HIV infection among men who have sex with men in Amsterdam. |
AHI, MSM, SOC |
39 |
2020 |
Defective HIV-1 proviruses produce viral proteins. |
ORFs, PBMCs |
40 |
2020 |
Deficits in bone strength, density and microarchitecture in women living with HIV: A cross-sectional HR-pQCT study. |
WLWH |
41 |
2020 |
Detectability of HIV Residual Viremia despite Therapy Is Highly Associated with Treatment with a Protease Inhibitor-Based Combination Antiretroviral Therapy. |
GEE, PI, RV, VL |
42 |
2020 |
Development and optimization of a simian immunodeficiency virus (SIV) droplet digital PCR (ddPCR) assay. |
ddPCR, MGB, NHP, SIV |
43 |
2020 |
Differences in location of cerebral white matter hyperintensities in children and adults living with a treated HIV infection: A retrospective cohort comparison. |
FLAIR, WMH |
44 |
2020 |
Disruption of brain network organization in patients with human immunodeficiency virus (HIV) infection. |
HAND, HIV |
45 |
2020 |
Disseminated Mycobacterium avium on HIV/AIDS: Historical and Current Literature Review. |
DMAC, PLHA |
46 |
2020 |
Distal Sensory Peripheral Neuropathy in Human Immunodeficiency Virus Type 1-Positive Individuals Before and After Antiretroviral Therapy Initiation in Diverse Resource-Limited Settings. |
DSPN, HIV, PLWH, RLSs |
47 |
2020 |
Do Combination Antiretroviral Therapy Regimens for HIV Infection Feature Diverse T-Cell Phenotypes and Inflammatory Profiles? |
--- |
48 |
2020 |
Does switching from multiple to single-tablet regimen containing the same antiretroviral drugs improve adherence? A group-based trajectory modeling analysis. |
STR |
49 |
2020 |
Drug Resistance Mutation Frequency of Single-Genome Amplification-Derived HIV-1 Polymerase Genomes in the Cerebrospinal Fluid and Plasma of HIV-1-Infected Individuals under Nonsuppressive Therapy. |
CHARTER, CNS, CSF, DRMs, HAND, SGA |
50 |
2020 |
Drug Resistance Mutations Against Protease, Reverse Transcriptase and Integrase Inhibitors in People Living With HIV-1 Receiving Boosted Protease Inhibitors in South Africa. |
bPI, GRT, HIV-1C, INSTIs, NNRTI, NRTI, PI, PIs, PLHIV-1, RAMs, RTIs |
51 |
2020 |
Dynamic Shifts in the HIV Proviral Landscape During Long Term Combination Antiretroviral Therapy: Implications for Persistence and Control of HIV Infections. |
ddPCR |
52 |
2020 |
Dyslipidaemia after switch to tenofovir alafenamide (TAF)-based cART regimens in a cohort of HIV-positive patients: what clinical relevance? |
aOR, CI, CV, ESC/EAS, LDL, TAF |
53 |
2020 |
Early and Successful Combination Antiretroviral Therapy Normalizes Survival Time in Patients Coinfected With Human Immunodeficiency Virus and Human T-cell Lymphotrophic Virus Type 1. |
HIV, HTLV-1, pVL |
54 |
2020 |
Effect of combination antiretroviral therapy on human immunodeficiency virus 1 specific antibody responses in subtype-C infected children. |
ADCC, bNAbs, HIV, NAb |
55 |
2020 |
Effect of combination antiretroviral therapy on the clinical manifestations, radiological characteristics, and disease severity of HIV-associated Talaromyces marneffei infection. |
CT, HIV |
56 |
2020 |
Effectiveness of dolutegravir-based antiretroviral therapy in a real-world setting in a Belgian cohort of 4101 HIV patients. |
ADR, DTG |
57 |
2020 |
Effects of Antiretroviral Therapy on CD4+ Cell Count, HIV Viral Load and Death in a South African Cohort: A Modelling Study. |
HAD, HAD |
58 |
2020 |
Effects of Brief Adjunctive Metformin Therapy in Virologically Suppressed HIV-Infected Adults on Polyfunctional HIV-Specific CD8 T cell Responses to PD-L1 Blockade. |
ICB, mAbs |
59 |
2020 |
Efficacy of Three Antiretroviral Regimens Initiated during Pregnancy: Clinical Experience in Rio de Janeiro. |
VL |
60 |
2020 |
Emergence of Drug Resistance in the Swiss HIV Cohort Study Under Potent Antiretroviral Therapy Is Observed in Socially Disadvantaged Patients. |
CI, HIV-1, MOR, SHCS |
61 |
2020 |
Epidemiologic and viral predictors of antiretroviral drug resistance among persons living with HIV in a large treatment program in Nigeria. |
ADR, CIs, ORs, PLWH |
62 |
2020 |
Extracellular Vesicle Activation of Latent HIV-1 Is Driven by EV-Associated c-Src and Cellular SRC-1 via the PI3K/AKT/mTOR Pathway. |
EV |
63 |
2020 |
Extracellular vesicle-mediated intercellular communication in HIV-1 infection and its role in the reservoir maintenance. |
EVs |
64 |
2020 |
Factors associated with immunosenescence during early adulthood in HIV-infected patients after durable efficient combination antiretroviral therapy. |
KRECs, TL, TRECs |
65 |
2020 |
Future approaches to clearing the latent human immunodeficiency virus reservoir: Beyond latency reversal. |
HIV |
66 |
2020 |
gamma-Non-symmetrically-dimasked TriPPPro-prodrugs as potential antivirals against HIV. |
NRTI, NTPs |
67 |
2020 |
Genetic Diversity, Compartmentalization, and Age of HIV Proviruses Persisting in CD4+ T Cell Subsets during Long-Term Combination Antiretroviral Therapy. |
--- |
68 |
2020 |
Health care issues affecting transgender people living with HIV: an opportunity for improvement. |
IQR, Tg, VL |
69 |
2020 |
Hepatitis C virus or hepatitis B virus coinfection and lymphoma risk in people living with HIV. |
HBV, HCV, NHL, OR |
70 |
2020 |
HIGH-FREQUENCY failure of combination antiretroviral therapy in paediatric HIV infection is associated with unmet maternal needs causing maternal NON-ADHERENCE. |
POC, SOC |
71 |
2020 |
Higher iron stores and the HFE 187C>G variant delay onset of peripheral neuropathy during combination antiretroviral therapy. |
ACTG, hs-CRP, PWH, sTfR |
72 |
2020 |
HIV and risk of dementia in older veterans. |
aHR, PLWH |
73 |
2020 |
HIV Care Continuum and Meeting 90-90-90 Targets: Cascade of Care Analyses of a U.S. Military Cohort. |
CI, DHHS, DoD, VS |
74 |
2020 |
HIV Infection and Neurocognitive Disorders in the Context of Chronic Drug Abuse: Evidence for Divergent Findings Dependent upon Prior Drug History. |
HAND |
75 |
2020 |
HIV infects astrocytes in vivo and egresses from the brain to the periphery. |
BBB, NSG, PBMCs |
76 |
2020 |
HIV therapeutic vaccines aimed at intensifying combination antiretroviral therapy. |
--- |
77 |
2020 |
HIV-1 DNA decay dynamics in early treated individuals: practical considerations for clinical trial design. |
--- |
78 |
2020 |
HIV-1 Maturation: Lessons Learned from Inhibitors. |
ALLINIs, CA, MIs, PR, SP1 |
79 |
2020 |
HIV-1 Persistence and Chronic Induction of Innate Immune Responses in Macrophages. |
CVD, HANA, HAND |
80 |
2020 |
HIV-1 Tat-Induced Astrocytic Extracellular Vesicle miR-7 Impairs Synaptic Architecture. |
CNS, EV, HIV-1, miR-7, NLGN2, PDGF-CC, Tat |
81 |
2020 |
HIV-associated neurocognitive disorder and HIV-associated myelopathy in a patient with a preserved CD4, but high viral load-a rarely reported phenomenon: a case report and literature review. |
HAM, HAND |
82 |
2020 |
HIV-Infected Mothers Who Decide to Breastfeed Their Infants Under Close Supervision in Belgium: About Two Cases. |
HIV, WHO |
83 |
2020 |
Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection. |
ddPCR, HIV |
84 |
2020 |
Hypervitaminosis A is associated with immunological non-response in HIV-1-infected adults: a case-control study. |
INR, VL |
85 |
2020 |
Identification of Combinations of Protein Kinase C Activators and Histone Deacetylase Inhibitors That Potently Reactivate Latent HIV. |
LRAs |
86 |
2020 |
Identification, management and outcomes of combination antiretroviral treatment failure in adolescents with perinatal HIV infection in Asia. |
LTFU, PHIVA |
87 |
2020 |
Immune reconstitution inflammatory syndrome in the central nervous system: Limitations for diagnosis in resource limited settings. |
CNS IRIS, CSF, RLS, TB |
88 |
2020 |
Immunological recovery failure in cART-treated HIV-positive patients is associated with reduced thymic output and RTE CD4+ Tcell death by pyroptosis. |
HIV, RTE |
89 |
2020 |
Immunology of EBV-Related Lymphoproliferative Disease in HIV-Positive Individuals. |
EBV, HIV, HL, LPD, NHL |
90 |
2020 |
Impact of low-level viraemia on virological failure among Asian children with perinatally acquired HIV on first-line combination antiretroviral treatment: a multicentre, retrospective cohort study. |
CLHIV, LLV, pVL, PYFU, VF |
91 |
2020 |
Impact of Population and Pharmacogenetics Variations on Efavirenz Pharmacokinetics and Immunologic Outcomes During Anti-Tuberculosis Co-Therapy: A Parallel Prospective Cohort Study in Two Sub-Sahara African Populations. |
BMI, TB |
92 |
2020 |
Incidence and Risk Factors for Invasive Pneumococcal Disease and Community-acquired Pneumonia in Human Immunodeficiency Virus-Infected Individuals in a High-income Setting. |
CAP, IPD, IRR, PLWH, PYFU |
93 |
2020 |
Incidence of and risk factors for tuberculosis among people with HIV on antiretroviral therapy in the United Kingdom. |
CI |
94 |
2020 |
Innovations for prevention and care of oral candidiasis in HIV-infected individuals: Are they available?-A workshop report. |
IRIS, OC |
95 |
2020 |
Integrating Comprehensive Geriatric Assessment Into HIV Care Systems in Indonesia: A Synthesis of Recent Evidence. |
CGA, HIV |
96 |
2020 |
Liberation from Dialysis Dependence in a Patient with HIV-Associated Nephropathy (HIVAN) after Combined Antiretroviral Therapy (cART). |
ESRD, HIVAN, HIVAN |
97 |
2020 |
Long-Term Impact of Calcium and Vitamin D Supplementation on Bone Density in HIV+ Patients with Documented Deficiencies. |
BMD, DEXA |
98 |
2020 |
Management of HIV-infected patients in the intensive care unit. |
--- |
99 |
2020 |
Management of Intraocular Infections in HIV. |
AIDS, HIV |
100 |
2020 |
Maximizing viral detection with SIV droplet digital PCR (ddPCR) assays. |
ddPCR, SIV |
|